Positive Phase 1 Parkinson’s Trial Results of New Therapy Reported by Prothena
News
Prothena recently presented results from a Phase 1b clinical trial investigating a new antibody therapy for the treatment of Parkinson’s disease at the 13th International Conference on Alzheimer’s and Parkinson’s Diseases ... Read more